Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1838]

HDAC inhibition sensitises triple-negative breast cancer cells to PARP...

Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA

HDAC inhibition sensitises triple-negative breast cancer cells to PARP inhibition ( Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA )

A need for clarity in clinical trial end points

Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA

A need for clarity in clinical trial end points ( Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA )

Neratinib shows beneficial effects in the treatment of HER2 mutated breast...

Prof Ron Bose – Washington University School of Medicine, St. Louis, USA

Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer ( Prof Ron Bose – Washington University School of Medicine, St. Louis, USA )

Adjuvant chemotherapy for locally recurrent breast cancer

Dr Stefan Aebi – Luzerner Kantonsspital, Switzerland

Adjuvant chemotherapy for locally recurrent breast cancer ( Dr Stefan Aebi – Luzerner Kantonsspital, Switzerland )

Breast cancer hypo-fractionated radiotherapy offers long-term tumour control

Prof John Yarnold – Institute of Cancer Research and Royal Marsden Hospital, UK

$Breast cancer hypo-fractionated radiotherapy offers long-term tumour control ( Prof John Yarnold – Institute of Cancer Research and Royal Marsden Hospital, UK )$

Effectiveness of sentinel lymph node surgery after chemotherapy in node...

Dr Judy Boughey – Mayo Clinic, Rochester USA

Effectiveness of sentinel lymph node surgery after chemotherapy in node-positive breast cancer ( Dr Judy Boughey – Mayo Clinic, Rochester USA )

Extending adjuvant trastuzumab treatment time provided no additional benefit

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium

Extending adjuvant trastuzumab treatment time provided no additional benefit ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )

Breast cancer genome sequencing identified HER2 mutations as targets for drug...

Prof Ron Bose - Washington University School of Medicine, St Louis, USA

Breast cancer genome sequencing identified HER2 mutations as targets for drug treatment ( Prof Ron Bose - Washington University School of Medicine, St Louis, USA )

Cognitive problems may be present before chemotherapy in women with breast...

Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor...

Cognitive problems may be present before chemotherapy in women with breast cancer ( Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor, USA )

BEATRICE study, adjuvant bevacizumab did not improve invasive disease-free...

Prof David Cameron - Edinburgh University, UK

BEATRICE study, adjuvant bevacizumab did not improve invasive disease-free survival in triple-negative breast cancer ( Prof David Cameron - Edinburgh University, UK )

Phase III trial did not show superiority of eribulin compared with capecitabine...

Dr Peter Kaufman - Norris Cotton Cancer Center, New Hampshire, USA

Phase III trial did not show superiority of eribulin compared with capecitabine in metastatic breast cancer ( Dr Peter Kaufman - Norris Cotton Cancer Center, New Hampshire, USA )

HDAC inhibitors sensitise triple-negative breast cancer cells to PARP...

Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA

HDAC inhibitors sensitise triple-negative breast cancer cells to PARP inhibition and cisplatin treatment ( Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA )

More from ecancer